Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 4.070
+0.010 (0.25%)
Jul 3, 2026, 5:29 PM CET
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of 429.45 million as of July 2, 2026. Its market cap has increased by 769.66% in one year.
Market Cap
429.45M
Enterprise Value
321.12M
Revenue
153.28M
Ranking
n/a
PE Ratio
4.94
Stock Price
4.07
Market Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 429.45M, an increase of 587.18%. That is a compound annual growth rate of 17.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 429.45M | 176.87% |
| Dec 30, 2025 | 155.11M | 40.43% |
| Dec 30, 2024 | 110.46M | -8.82% |
| Dec 29, 2023 | 121.14M | 449.78% |
| Dec 30, 2022 | 22.03M | -88.47% |
| Dec 30, 2021 | 191.05M | 17.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AlzeCure Pharma AB | 792.91M |
| Xspray Pharma AB | 734.96M |
| Oncopeptides AB | 650.25M |
| FluoGuide | 634.35M |
| Cantargia AB | 539.49M |
| Corline Biomedical AB | 463.86M |
| Intervacc AB | 445.78M |
| Ascelia Pharma AB | 438.00M |